Submit Abstract
Deadline for submission of abstracts: Sept 23, 2024
Abstracts are invited by Sept 23, 2024. A selection of the best abstracts will be nominated for oral presentation. The rest will be poster only. All accepted abstracts will be published in The Lancet Regional Health—Western Pacific.
To submit your abstract, please follow the instructions here
The Summit will consider abstracts focused on breast, gastrointestinal, hepatobiliary, or lung cancer as well as on chronic obstructive pulmonary disease.
All abstracts should be original research. We will consider clinical trials, prospective studies, retrospective analyses, meta-analyses, and observational cohort or case-control studies. However, reviews, opinion pieces, case series, or case reports will not be considered. The research should have ethics approval and clinical trials should be prospectively registered in a publicly accessible database. We also encourage registration of meta-analyses.
We look forward to reading your work and welcoming you to the Summit.
All abstracts will be refereed and a criterion of rejection will be lack of originality.
A condition of submission is that, if accepted, the paper will be presented at the conference by one of the authors.
Successfully submitted abstracts will be acknowledged with an electronic receipt including an abstract reference number, which should be quoted in all correspondence.
If you do not receive acknowledgement for your abstract submission or you wish to make any essential revisions to an abstract already submitted, please DO NOT RESUBMIT your abstract, as this may lead to duplication. Please contact the Conference Content Executive (Please do not email credit card information under any circumstances) with details of any revisions or queries. Please quote your reference number if you have one.